Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares saw an uptick in trading volume on Tuesday . 103,237 shares traded hands during trading, an increase of 88% from the previous session’s volume of 55,026 shares.The stock last traded at $3.6030 and had previously closed at $3.8150.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Raia Drogasil has a consensus rating of “Hold”.
Get Our Latest Report on Raia Drogasil
Raia Drogasil Stock Down 5.6%
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Articles
- Five stocks we like better than Raia Drogasil
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
- 3 Energy Stocks Racing to Fix AI’s Power Problem
- No Space For Panic: T-Mobile Shrugs Off The Starlink Threat
- Prepare for the Next Wave of Factory Automation With These 3 Standout Names
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
